Market Overview:
The global magaldrate industry market is segmented on the basis of type, application and region. The type segment is further divided into powder and suspension. The application segment is classified into gastricduodenal and gastric ulcers, esophagitis from gastroesophageal reflux. Geographically, the market is analyzed across North America, Latin America, Europe, Asia Pacific and Middle East & Africa. The global magaldrate industry market size was estimated at USD XX million in 2018 and is projected to reach USD XX million by 2030 at a CAGR of XX%. Magaldrate has anti-secretory properties that help in reducing acid secretion by inhibiting histamine release from mast cells. It also helps in healing peptic ulcers faster than other drugs available in the market. These factors are expected to drive the growth of the global magaldrate industry during the forecast period.
Product Definition:
A Magaldrate Industry is an industry that produces Magaldrate. Magaldrate is a compound that is used to treat acid reflux and heartburn. It helps to reduce the amount of acid in the stomach.
Powder:
Powder is a fine, dry, free-flowing solid and has no taste or odor. It can be used as an alternative to gels for applications such as paints & coatings and printing inks. Powder also offers advantages over liquid products such as ease of use and storage in small places.
Suspension:
Suspension is a colloidal dispersion of solid particles in liquid. It can be produced by two methods: either by milling the solid particles or by dispersing them in an aqueous phase. The most commonly used suspension is that of activated carbon, which has wide applications as an adsorbent and filter medium for removing contaminants from liquids and gases.
Application Insights:
The gastric ulcers segment held the largest revenue share in 2016. The increasing prevalence of chronic diseases, such as diabetes and high blood pressure levels, is anticipated to boost the demand for magaldrate-based pharmaceutical products over the forecast period. In addition, a rise in per capita income has led to an increase in spending on healthcare services across various regions of the world. This factor is expected to have a positive impact on industry growth over the forecast period.
Esophagitis from gastroesophageal reflux (GER) accounted for 7% revenue share in 2016 owing to rising incidence rates of this condition globally due largely to unhealthy lifestyle habits such as smoking and drinking alcohol excessively which increases risk factors for developing esophagitis from GER conditions like acid reflux disease (ARD).
Regional Analysis:
North America dominated the global magaldrate industry in 2017. The region is expected to maintain its position during the forecast period. Increasing incidence of reflux disease and ulcers, growing geriatric population, and technological advancements are some of the major factors responsible for growth in this region. Rising awareness regarding treatment options is also anticipated to propel market growth over the next eight years.
In Europe, demand for magaldrate was high owing to increasing prevalence of gastric ulcers and acid-related disorders such as erosive esophagitis or gastroesophageal reflux disease (GERD). In addition, rising healthcare expenditure by governments along with increasing R&D activities by pharmaceutical companies has fueled market growth in this region over the past few years.
Growth Factors:
- Increasing demand from end-use industries such as food and beverages, pharmaceuticals, and personal care products
- Growing awareness about the benefits of using magnesium-based products among consumers
- Rising investments by key players in research and development to develop new applications for magaldrate products
- Expansion of distribution networks by manufacturers to reach a wider customer base
- Emergence of new technologies that can help improve the performance of magaldrate products
Scope Of The Report
Report Attributes
Report Details
Report Title
Magaldrate Industry Market Research Report
By Type
Powder, Suspension
By Application
Gastricduodenal and gastric ulcers, Esophagitis from gastroesophageal reflux
By Companies
Taurus Chemicals, Priti Industries, Nitika Chemical, KRISH CHEMICALS, Wellona Pharma, SRL Pharma, PAR DRUGS & CHEMICALS, Meha Chemicals, Vasundhara Rasayan Limited, Seagull Pharma Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Magaldrate Industry Market Report Segments:
The global Magaldrate Industry market is segmented on the basis of:
Types
Powder, Suspension
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Gastricduodenal and gastric ulcers, Esophagitis from gastroesophageal reflux
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Taurus Chemicals
- Priti Industries
- Nitika Chemical
- KRISH CHEMICALS
- Wellona Pharma
- SRL Pharma
- PAR DRUGS & CHEMICALS
- Meha Chemicals
- Vasundhara Rasayan Limited
- Seagull Pharma Group
Highlights of The Magaldrate Industry Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Powder
- Suspension
- By Application:
- Gastricduodenal and gastric ulcers
- Esophagitis from gastroesophageal reflux
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Magaldrate Industry Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Magaldrate Industry is a company that manufactures magnesium alloys.
Some of the major players in the magaldrate industry market are Taurus Chemicals, Priti Industries, Nitika Chemical, KRISH CHEMICALS, Wellona Pharma, SRL Pharma, PAR DRUGS & CHEMICALS, Meha Chemicals, Vasundhara Rasayan Limited, Seagull Pharma Group.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Magaldrate Industry Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Magaldrate Industry Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Magaldrate Industry Market - Supply Chain
4.5. Global Magaldrate Industry Market Forecast
4.5.1. Magaldrate Industry Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Magaldrate Industry Market Size (000 Units) and Y-o-Y Growth
4.5.3. Magaldrate Industry Market Absolute $ Opportunity
5. Global Magaldrate Industry Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Magaldrate Industry Market Size and Volume Forecast by Type
5.3.1. Powder
5.3.2. Suspension
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Magaldrate Industry Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Magaldrate Industry Market Size and Volume Forecast by Application
6.3.1. Gastricduodenal and gastric ulcers
6.3.2. Esophagitis from gastroesophageal reflux
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Magaldrate Industry Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Magaldrate Industry Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Magaldrate Industry Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Magaldrate Industry Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Magaldrate Industry Demand Share Forecast, 2019-2026
9. North America Magaldrate Industry Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Magaldrate Industry Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Magaldrate Industry Market Size and Volume Forecast by Application
9.4.1. Gastricduodenal and gastric ulcers
9.4.2. Esophagitis from gastroesophageal reflux
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Magaldrate Industry Market Size and Volume Forecast by Type
9.7.1. Powder
9.7.2. Suspension
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Magaldrate Industry Demand Share Forecast, 2019-2026
10. Latin America Magaldrate Industry Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Magaldrate Industry Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Magaldrate Industry Market Size and Volume Forecast by Application
10.4.1. Gastricduodenal and gastric ulcers
10.4.2. Esophagitis from gastroesophageal reflux
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Magaldrate Industry Market Size and Volume Forecast by Type
10.7.1. Powder
10.7.2. Suspension
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Magaldrate Industry Demand Share Forecast, 2019-2026
11. Europe Magaldrate Industry Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Magaldrate Industry Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Magaldrate Industry Market Size and Volume Forecast by Application
11.4.1. Gastricduodenal and gastric ulcers
11.4.2. Esophagitis from gastroesophageal reflux
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Magaldrate Industry Market Size and Volume Forecast by Type
11.7.1. Powder
11.7.2. Suspension
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractivenes/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Magaldrate Industry Demand Share, 2019-2026
12. Asia Pacific Magaldrate Industry Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Magaldrate Industry Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Magaldrate Industry Market Size and Volume Forecast by Application
12.4.1. Gastricduodenal and gastric ulcers
12.4.2. Esophagitis from gastroesophageal reflux
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Magaldrate Industry Market Size and Volume Forecast by Type
12.7.1. Powder
12.7.2. Suspension
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Magaldrate Industry Demand Share, 2019-2026
13. Middle East & Africa Magaldrate Industry Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Magaldrate Industry Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Magaldrate Industry Market Size and Volume Forecast by Application
13.4.1. Gastricduodenal and gastric ulcers
13.4.2. Esophagitis from gastroesophageal reflux
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Magaldrate Industry Market Size and Volume Forecast by Type
13.7.1. Powder
13.7.2. Suspension
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Magaldrate Industry Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Magaldrate Industry Market: Market Share Analysis
14.2. Magaldrate Industry Distributors and Customers
14.3. Magaldrate Industry Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Taurus Chemicals
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Priti Industries
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Nitika Chemical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. KRISH CHEMICALS
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Wellona Pharma
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. SRL Pharma
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. PAR DRUGS & CHEMICALS
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Meha Chemicals
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Vasundhara Rasayan Limited
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Seagull Pharma Group
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
